Simplex Trading
APYX icon

Simplex Trading’s Apyx Medical APYX Stock Holding History

Simplex Trading’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.12K Buy
2,200
+1,800
+450% +$6.73K ﹤0.01% 7531
2025
Q4 		$1.4K Sell
400
-2,000
-83% -$6.97K ﹤0.01% 7942
2025
Q3 		$5K Hold
2,400
– – ﹤0.01% 8270
2025
Q2 		$5K Buy
+2,400
New +$3.38K ﹤0.01% 7701
2024
Q1 		– Sell
-18,600
Closed -$48K – 8788
2023
Q4 		$48K Sell
18,600
-2,400
-11% -$5.81K ﹤0.01% 6111
2023
Q3 		$67K Sell
21,000
-37,800
-64% -$176K ﹤0.01% 5517
2023
Q2 		$295K Buy
+58,800
New +$298K ﹤0.01% 3868
2022
Q3 		– Sell
-3,700
Closed -$21K – 9837
2022
Q2 		$21K Buy
+3,700
New +$19K ﹤0.01% 7524
2021
Q2 		– Sell
-10
Closed -$9K – 9976
2021
Q1 		$9K Buy
+10
New +$100 ﹤0.01% 7926
2019
Q2 		– Sell
-193
Closed -$121K – 7040
2019
Q1 		$121K Buy
+193
New +$1.49K ﹤0.01% 4138
2018
Q4 		– Sell
-64
Closed -$45K – 6943
2018
Q3 		$45K Buy
+64
New +$356 ﹤0.01% 5261

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Simplex Trading's APYX Position: Q1 2026 in Review

Simplex Trading reduced its Apyx Medical (APYX) stake by 26% in Q1 2026, selling an estimated $9.5K and leaving 7,392 shares worth $27.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6485.

Simplex Trading first reported a position in APYX in Q3 2018 and has held it in 23 quarters since. The position peaked at $179K in Q4 2018. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Simplex Trading held 7,392 shares of Apyx Medical worth $27.3K as of Q1 2026.
  • Simplex Trading sold 2,542 Apyx Medical shares in Q1 2026, an estimated $9.5K.
  • Apyx Medical made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6485 holding.
  • Simplex Trading first reported a position in Apyx Medical in Q3 2018 and has held it in 23 quarters since.
  • Simplex Trading's Apyx Medical position peaked at $179K in Q4 2018.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.